Presentation TCT 2022

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

Presenter: Majd Hemam

September 18, 2022

REGISTER for free or LOG IN to view this content

TCT 344: UTILIZING CARDIAC CONTRACTILITY MODULATION THERAPY FIRST IN PATIENTS WITH LOW EF 25-35% IMPROVES LV FUNCTION AND HEART FAILURE STATUS WITHOUT THE NEED FOR CONCOMITATNT IMPLANTABLE DEFIBRILLATOR: EARLY US URBAN EXPERIENCE IN AN ACADEMIC TERTIARY…

Heart Failure

TCT 2022

Up Next

Presentation TCT 2022

TCT 345: Right ventricular failure in patients presenting with Takotsubo Cardiomyopathy

Presenter: Suchith Shetty

September 18, 2022

More slides +

Presentation TCT 2022

TCT 346: Safety of right and left ventricular endomyocardial biopsy in Heart Transplant and Cardiomyopathy patients

Presenter: Konstantinos Bermpeis

September 18, 2022

Presentation TCT 2022

TCT 348: Evaluating improvement in regional left ventricular function after hybrid minimally invasive left ventricular reconstruction in ischemic cardiomyopathy: CT- or MRI-based inward displacement to overcome current shortcomings in imaging

Presenter: Romy Hegeman

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.